According to Mediclin's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.6501. At the end of 2024 the company had a P/S ratio of 0.1533.
Year | P/S ratio | Change |
---|---|---|
2024 | 0.1533 | -15.57% |
2023 | 0.1816 | -26.44% |
2022 | 0.2468 | -8.34% |
2021 | 0.2693 | -9.21% |
2020 | 0.2966 | -18.46% |
2019 | 0.3638 | -11.59% |
2018 | 0.4115 | -19.23% |
2017 | 0.5095 | 11.4% |
2016 | 0.4574 | 30.26% |
2015 | 0.3511 | 20.62% |
2014 | 0.2911 | -29.32% |
2013 | 0.4119 | 4.81% |
2012 | 0.3930 | 15.89% |
2011 | 0.3391 | -0.53% |
2010 | 0.3409 |